123 related articles for article (PubMed ID: 18956548)
1. [HIV in Mexican blood donors and estimated transfusional risk].
Arreguín V; Alvarez P; Simón JI; Valderrama JA; Macías AE
Rev Invest Clin; 2008; 60(4):278-83. PubMed ID: 18956548
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
[TBL] [Abstract][Full Text] [Related]
3. Risk of HIV infection from blood transfusion in Montreal.
Remis RS; Delage G; Palmer RW
CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
[TBL] [Abstract][Full Text] [Related]
5. [Comments to the manuscript; HIV in Mexican blood donors and estimated transfusional risk].
Sánchez-Guerrero SA
Rev Invest Clin; 2008; 60(6):545-6; author reply 547. PubMed ID: 19378840
[No Abstract] [Full Text] [Related]
6. Prevalence of HIV infection in school based and other young donors during the 2002 and 2003 period.
Mandisodza AR; Charuma H; Masoha A; Musekiwa Z; Mvere D; Abayomi A
Afr J Med Med Sci; 2006 Mar; 35(1):69-72. PubMed ID: 17209330
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors].
Rivera-López MR; Zavala-Méndez C; Arenas-Esqueda A
Gac Med Mex; 2004; 140(6):657-60. PubMed ID: 15633577
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
9. HIV seroprevalence among blood donors in southern Brazil in the decade of 1990.
Kupek EJ
Braz J Infect Dis; 2000 Oct; 4(5):217-25. PubMed ID: 11185542
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors.
Nissapatorn V; Kamarulzaman A; Init I; Tan LH; Rohela M; Norliza A; Chan LL; Latt HM; Anuar AK; Quek KF
Med J Malaysia; 2002 Sep; 57(3):304-10. PubMed ID: 12440270
[TBL] [Abstract][Full Text] [Related]
11. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
[TBL] [Abstract][Full Text] [Related]
12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
13. [Infectious markers among blood donors in Democratic Republic of Congo (DRC)].
Batina A; Kabemba S; Malengela R
Rev Med Brux; 2007; 28(3):145-9. PubMed ID: 17708468
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.
Karki S; Ghimire P; Tiwari BR; Shrestha AC; Gautam A; Rajkarnikar M
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):66-70. PubMed ID: 19323036
[TBL] [Abstract][Full Text] [Related]
15. [The survey of prevalence of HIV infection among paid blood donors in one county in China].
Yan J; Zheng X; Zhang X; Liu S; Zhang Y; Wang C; Liu S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):10-3. PubMed ID: 11860747
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus seroprevalence and 'cytomegalovirus-safe' seropositive blood donors.
Badami KG; McQuilkan-Bickerstaffe S; Wells JE; Parata M
Epidemiol Infect; 2009 Dec; 137(12):1776-80. PubMed ID: 19480727
[TBL] [Abstract][Full Text] [Related]
17. [The epidemiological study of HIV infection among paid blood donors in one county of China].
Zheng X; Wang Z; Xu J; Huang S; Wang C; Li Z; Wang L; Zhang G; Gao M; Li H; Qu S; Cui W; Li X; Wei W
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):253-5. PubMed ID: 11860792
[TBL] [Abstract][Full Text] [Related]
18. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
Maresch C; Schluter PJ; Wilson AD; Sleigh A
Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
[TBL] [Abstract][Full Text] [Related]
19. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
20. [Effects of health legislation against HIV in blood donation in Guadalajara, Mexico].
Vázquez-Valls E; Torres-Mendoza BM; Jáuregui-Ríos ML; Campos-López PI
Salud Publica Mex; 1990; 32(1):38-42. PubMed ID: 2330512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
